关注
Luca Valenti
Luca Valenti
Associate Professor of Internal Medicine, Università degli Studi di Milano, Fondazione Ca' Granda
在 unimi.it 的电子邮件经过验证
标题
引用次数
年份
[709] BASELINE ALT AND FERRITIN PREDICT HISTOLOGICAL FINDINGS IN NAFLD
AL Fracanzani, L Valenti, E Fatta, C Bertelli, E Pulixi, S Fargion
Journal of Hepatology, S267-S268, 2007
2007
[769] IRON DEPLETION BY PHLEBOTOMY IMPROVES INSULIN RESISTANCE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERFERRITINEMIA; EVIDENCE FROM A CASE CONTROL STUDY
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, E Vanni, ...
Journal of Hepatology, S288-S289, 2007
12007
[94] RISK OF EARLY ATHEROSCLEROSIS BY CAROTID ARTERY INTIMA-MEDIA THICKNESS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE AND LOW VISCERAL ADIPOSITY
M Porzio, L Burdick, L Valenti, C Bertelli, E Fatta, C Masetti, S Fargion, ...
Nutrition, Metabolism and Cardiovascular Diseases, S24, 2009
2009
1042 Mitochondrial superoxide dismutase ALA9VAL polymorphism and phenotypic expression of hereditary hemochromatosis
L Valenti, P Dongiovanni, E Mangano, AL Fracanzani, E Fatta, C Bertelli, ...
Hepatology, 657, 2003
2003
1080 LOW RATES OF SVR TO PEGINTERFERON PLUS RIBAVIRIN IN HCV GENOTYPE 1 IL28B RS12979860 CC CIRRHOTIC PATIENTS WITHOUT RAPID VIROLOGICAL RESPONSE
E Degasperi, A Aghemo, E Galmozzi, L Valenti, MG Rumi, ...
Journal of Hepatology, S425, 2012
2012
127 homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al-Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Journal of Hepatology, S57, 2010
22010
136 THE A736V TMPRSS6 POLYMORPHISM IS ASSOCIATED WITH THE PENETRANCE OF HEREDITARY HEMOCHROMATOSIS AND HEPATOCELLULAR CARCINOMA IN C282Y+/+ PATIENTS
L Valenti, AL Fracanzani, R Rametta, G Soverini, S Pelusi, P Dongiovanni, ...
Journal of Hepatology, S59, 2012
2012
1362 RISK OF OBSTRUCTIVE SLEEP APNEA SYNDROME AND ASSOCIATION WITH LIVER DAMAGE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE WITHOUT SEVERE OBESITY
EA Pulixi, E Tobaldini, AL Fracanzani, N Montano, S Fargion, L Valenti
Journal of Hepatology, S547-S548, 2013
2013
1373 EFFECT OF IRON DEPLETION ON LIVER DAMAGE IN NONALCOHOLIC FATTY LIVER DISEASE: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL
L Valenti, AL Fracanzani, P Dongiovanni, E Fatta, EA Pulixi, M Maggioni, ...
Journal of Hepatology, S552-S553, 2013
2013
1397 ATYPICAL JUVENILE HEMOCHROMATOSIS ASSOCIATED WITH HETEROZYGOSITY FOR NOVEL HEMOJUVELIN MUTATIONS
S Pelusi, R Rametta, C Della Corte, P Francalanci, P Dongiovanni, ...
Journal of Hepatology, S561, 2013
2013
18 TNFα promoter polymorphisms and insulin resistance in HCV-related fatty liver
L Valenti, EA Pulixi, AL Fracanzani, P Dongiovanni, C Bertelli, E Fatta, ...
Digestive and Liver Disease, A15, 2003
2003
35 INCREASED FERRITIN PREDICTS VASCULAR DAMAGE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
L Valenti, L Burdick, C Bertelli, S Fargion, AL Fracanzani
Journal of Hepatology, S16, 2008
2008
399 PNPLA3 I148M AFFECTS LIVER STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS B
M Vigano, L Valenti, P Lampertico, BM Motta, R D'Ambrosio, F Facchetti, ...
Journal of Hepatology, S164, 2013
2013
448 IL28B GENOTYPE IS NOT ASSOCIATED WITH INSULIN RESISTANCE IN CHRONIC HEPATITIS C PATIENTS
E Degasperi, L Valenti, A Aghemo, R De Francesco, R Soffredini, ...
Journal of Hepatology, S183, 2013
2013
89 Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease: A case control study
AL Fracanzani, L Burdick, S Rasselli, P Pedotti, L Grigore, G Santorelli, ...
Journal of Hepatology 44, S39-S40, 2006
52006
911 Iron and insulin resistance: effect of iron manipulation on insulin receptor in HEPG2 cells
P Dongiovanni, L Valenti, L Carmagnola, F Di Caterino, AL Fracanzani, ...
Hepatology, 597, 2003
2003
919 EVALUATION OF PATIENTS WITH NAFLD WITH OR WITHOUT INCREASED ALT
AL Fracanzani, L Valenti, E Bugianesi, G Marchesini, M Andreoletti, ...
Journal of Hepatology, S344-S345, 2008
2008
96 IRON DEPLETION BY DEFEROXAMINE UPREGULATES GLUCOSE UPTAKE AND INSULIN SIGNALING IN HEPATOCYTES AND IN A RAT MODEL OF FATTY LIVER
P Dongiovanni, L Valenti, AL Fracanzani, S Gatti, G Cairo, S Fargion
Journal of Hepatology, S41, 2008
2008
A “systems medicine” approach to the study of non-alcoholic fatty liver disease
S Petta, L Valenti, E Bugianesi, G Targher, S Bellentani, F Bonino, ...
Digestive and Liver Disease 48 (3), 333-342, 2016
792016
A 360-degree overview of paediatric NAFLD: recent insights
V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro
Journal of hepatology 58 (6), 1218-1229, 2013
2052013
系统目前无法执行此操作,请稍后再试。
文章 1–20